INDICATION: Abiraterone acetate is indicated for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel.
WARNING: Drug, To be sold by retail on the prescription of Registered Oncologist